Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,948.00    4.00 (0.08%)
Bid:
4,956.00
Ask:
4,964.00
Spread: 8.00 (0.161%)
Market Cap: £2.31b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Pre-close trading update

17 Dec 2009 07:00

RNS Number : 2597E
Morgan Sindall PLC
17 December 2009
Β 

ο»Ώ

17 Dec 2009

Morgan Sindall plc

Morgan Sindall plc, the construction and regeneration group, provides the following period end trading update in advance of the announcement of its preliminary results for the year ended 31 December 2009, expected to be in late February 2010.Β 

Trading

As previously announced in our Interim Management Statement on 10 November, Morgan Sindall remains on track to achieve its expectations for the current year, despite the challenging market conditions in which it is operating.Β 

Fit Out is performing strongly in tough market conditions with margins remaining robust and it continues to see a recovery in the level of tendering activity.

Construction is still experiencing healthy demand from the public sector and, in particular, is currently advancing two major projects at preferred bidder stage, Tayside Mental Health (Β£100m) and Hull BSF (Β£200m). We expect to achieve financial close on these projects during the first quarter of 2010. There remains considerable uncertainty over future public spending commitments.

Infrastructure Services continues to perform well in reasonably buoyant market conditions and the division continues to progress a number of major opportunities. Although the bidding processes are proving more protracted than initially anticipated, we continue to await the outcome of preferred bidder decisions on a number of contracts.Β 

Affordable Housing is still seeing a reasonable pipeline of refurbishment and new build social housing opportunities. This is complemented by improvements in demand for open market housing with sales continuing to improve.

Urban Regeneration's market remains subdued although we expect recovery in market conditions in the longer term.

The Investments division is seeing a strong pipeline of opportunities and we expect that it will increase its level of bidding activity in 2010, thereby taking advantage of the Group's increasing ability to deliver larger and more complex projects since the acquisition made in 2007.

Outlook

The Group's forward order book has reduced from Β£3.6bn to Β£3.2bn since 30 June 2009. However, this forward order book is supplemented by over Β£900m of projects at preferred bidder stage, all of which have been awarded during the second half of this year.Β 

We remain mindful of the challenges facing the sector in the longer term and continue to shape our business accordingly. Each of our divisions continues to particularly focus on cash management, cost reduction and supply chain improvements, as well as responding to market growth opportunities where they present themselves.

In summary, Morgan Sindall is on track to meet our expectations for 2009 and is well placed to meet the challenges and opportunities in 2010.

Enquiries:

MorganΒ SindallΒ plc

Tel:Β 020Β 7307Β 9200

PaulΒ Smith,Β ChiefΒ Executive

DavidΒ Mulligan,Β FinanceΒ Director

BlytheΒ WeighΒ Communications

Tel:Β 020Β 7138Β 3204Β 

TimΒ Blythe

Mob:Β 07816Β 924626

PaulΒ Weigh

Mob:Β 07989Β 129658Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTCKAKBOBDDNBD
Date   Source Headline
1st Nov 20187:00 amRNSTrading Update
29th Oct 201811:30 amRNSNotice of Trading Update
22nd Oct 20189:01 amRNSBlock listing Interim Review
9th Oct 20184:08 pmRNSHolding(s) in Company
1st Oct 201810:08 amRNSTotal Voting Rights
28th Sep 20183:47 pmRNSHolding(s) in Company
27th Sep 20188:00 amRNSDirectorate Change
24th Sep 20188:18 amRNSHolding(s) in Company
4th Sep 20184:15 pmRNSHolding(s) in Company
3rd Sep 201812:02 pmRNSHolding(s) in Company
3rd Sep 20189:25 amRNSTotal Voting Rights
14th Aug 20187:00 amRNSDirectorate Change
8th Aug 20187:00 amRNSHalf-year Report
3rd Aug 20183:10 pmRNSHolding(s) in Company
1st Aug 20189:47 amRNSTotal Voting Rights
11th Jul 20183:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSNotice of Results
2nd Jul 201811:31 amRNSTotal Voting Rights
4th Jun 20184:34 pmRNSHolding(s) in Company
1st Jun 20184:30 pmRNSTotal Voting Rights
16th May 20188:00 amRNSAdditional Listing
4th May 201812:37 pmRNSResult of AGM
4th May 20187:00 amRNSAGM Trading Update
30th Apr 201810:17 amRNSTotal Voting Rights
23rd Apr 20189:15 amRNSBlock listing Interim Review
17th Apr 20187:00 amRNSMorgan Sindall Group Agrees £2bn Joint Venture
29th Mar 20185:29 pmRNSTotal Voting Rights
26th Mar 201812:25 pmRNSAnnual Financial Report
20th Mar 20182:38 pmRNSHolding(s) in Company
7th Mar 20189:28 amRNSDirector/PDMR Shareholding
7th Mar 20189:27 amRNSDirector/PDMR Shareholding
5th Mar 20183:49 pmRNSDirector/PDMR Shareholding
28th Feb 201811:19 amRNSTotal Voting Rights
26th Feb 20189:43 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
1st Feb 201810:45 amRNSTotal Voting Rights
30th Jan 20182:33 pmRNSHolding(s) in Company
29th Jan 20183:10 pmRNSDirectorate Change
15th Jan 201812:38 pmRNSStatement re: Carillion plc
8th Jan 20187:00 amRNSNotice of Results
3rd Jan 20189:08 amRNSTotal Voting Rights
14th Dec 20178:00 amRNSAdditional Listing
1st Dec 20171:00 pmRNSTotal Voting Rights
1st Dec 201712:37 pmRNSDirector/PDMR Shareholding
28th Nov 20175:13 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSPartnership Homes MOD Contract
24th Nov 20172:55 pmRNSHolding(s) in Company
22nd Nov 20177:00 amRNSAnalyst and Investor Evening Reception
2nd Nov 201712:50 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.